Sight Sciences Files 8-K for Material Agreement

TL;DR

Sight Sciences filed an 8-K on 9/30/25 for a material agreement & financials.

AI Summary

Sight Sciences, Inc. filed an 8-K on September 30, 2025, reporting an entry into a material definitive agreement and the filing of financial statements and exhibits. The company, incorporated in Delaware with its principal executive offices in Menlo Park, California, operates in the surgical and medical instruments sector.

Why It Matters

This filing indicates a significant business development or contractual change for Sight Sciences, Inc., which could impact its operations and financial standing.

Risk Assessment

Risk Level: low — The filing is a standard corporate disclosure and does not inherently present new risks.

Key Numbers

• 001-40587 — SEC File Number (Identifies the company's filing with the SEC.)
• 80-0625749 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• Sight Sciences, Inc. (company) — Registrant
• Delaware (jurisdiction) — State of Incorporation
• Menlo Park, California (location) — Principal Executive Offices
• September 30, 2025 (date) — Date of Report

FAQ

Key Financial Figures

• $0.001 — nge on which registered Common Stock, $0.001 par value per share SGHT The Nasdaq
• $65.0 million — the aggregate principal amount of up to $65.0 million. The Amendment was approved by all of t
• $10.0 million — o reallocate an undrawn and unavailable $10.0 million tranche by increasing from $15.0 millio
• $15.0 million — 10.0 million tranche by increasing from $15.0 million to $25.0 million the amount available t
• $25.0 million — che by increasing from $15.0 million to $25.0 million the amount available to draw through th
• $5.0 m — st only period in minimum increments of $5.0 million, subject to the sole approval of
• $50,000 — ent, the Company paid Hercules a fee of $50,000, for the benefit of the lenders, plus c

Filing Documents

• sght-20250930.htm (8-K) — 50KB
• sght-ex10_1.htm (EX-10.1) — 112KB
• 0001193125-25-225041.txt ( ) — 287KB
• sght-20250930.xsd (EX-101.SCH) — 26KB
• sght-20250930_htm.xml (XML) — 5KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. Third Amendment to Loan and Security Agreement On September 30, 2025 (the "Amendment Date"), Sight Sciences, Inc. (the "Company") entered into a third amendment (the "Amendment") to its Loan and Security Agreement (as amended, the "Hercules Loan Agreement") with Hercules Capital, Inc. ("Hercules") and certain of its affiliates (collectively with Hercules, the "Lenders") entered into in January 2024. The Hercules Loan Agreement provides for a senior secured term loan facility in the aggregate principal amount of up to $65.0 million. The Amendment was approved by all of the Lenders. The Amendment amends the Hercules Loan Agreement to provide for an additional six-month extension of the interest only period, to now extend to February 1, 2027. The Hercules Loan Agreement provided for the availability of additional tranches to the Company, contingent upon the achievement of certain performance milestones. The Amendment amends the Hercules Loan Agreement to reallocate an undrawn and unavailable $10.0 million tranche by increasing from $15.0 million to $25.0 million the amount available to draw through the interest only period in minimum increments of $5.0 million, subject to the sole approval of Hercules' investment committee, maintaining the maximum $65.0 million credit facility. Pursuant to the Amendment, as consideration for the above amendments to the Hercules Loan Agreement, the Company paid Hercules a fee of $50,000, for the benefit of the lenders, plus certain costs and expenses. The description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K (this "Current Report") and is incorporated herein by reference. Cautionary Note Regarding Forward-Looking Statements This Current Report, together with other statements and information publicly diss

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Third Amendment to Loan and Security Agreement, dated September 30, 2025, by and among Sight Sciences, Inc., certain affiliates of Hercules Capital, Inc., and Hercules Capital, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sight Sciences, Inc. Date: September 30, 2025 By: /s/ Alison Bauerlein Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR